Literature DB >> 26842972

Evaluation of abnormal liver function tests.

Swastik Agrawal1, Radha K Dhiman1, Jimmy K Limdi2.   

Abstract

Incidentally detected abnormality in liver function tests is a common situation encountered by physicians across all disciplines. Many of these patients do not have primary liver disease as most of the commonly performed markers are not specific for the liver and are affected by myriad factors unrelated to liver disease. Also, many of these tests like liver enzyme levels do not measure the function of the liver, but are markers of liver injury, which is broadly of two types: hepatocellular and cholestatic. A combination of a careful history and clinical examination along with interpretation of pattern of liver test abnormalities can often identify type and aetiology of liver disease, allowing for a targeted investigation approach. Severity of liver injury is best assessed by composite scores like the Model for End Stage Liver Disease rather than any single parameter. In this review, we discuss the interpretation of the routinely performed liver tests along with the indications and utility of quantitative tests. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  liver function

Mesh:

Substances:

Year:  2016        PMID: 26842972     DOI: 10.1136/postgradmedj-2015-133715

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  25 in total

1.  Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter?

Authors:  Andrew D Schreiner; William P Moran; Jingwen Zhang; Elizabeth B Kirkland; Marc E Heincelman; Samuel O Schumann Iii; Patrick D Mauldin; Don C Rockey
Journal:  J Investig Med       Date:  2018-06-25       Impact factor: 2.895

2.  Reference intervals for serum bilirubin, urea, and uric acid in healthy Chinese geriatric population.

Authors:  Yuanqing Yang; Hongmin Jiang; Aiguo Tang; Zhongyuan Xiang
Journal:  J Clin Lab Anal       Date:  2017-09-18       Impact factor: 2.352

3.  When Do Clinicians Follow-up Abnormal Liver Tests in Primary Care?

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Elizabeth B Kirkland; Marc E Heincelman; Samuel O Schumann; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med Sci       Date:  2019-04-20       Impact factor: 2.378

4.  Use In Silico and In Vitro Methods to Screen Hepatotoxic Chemicals and CYP450 Enzyme Inhibitors.

Authors:  Yitong Liu
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Value of Liver Function Tests in Cirrhosis.

Authors:  Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2021-11-14

6.  Cholesterol-induced leucine aminopeptidase 3 (LAP3) upregulation inhibits cell autophagy in pathogenesis of NAFLD.

Authors:  Lina Feng; Yanping Chen; Ke Xu; Yingchao Li; Farooq Riaz; Kaikai Lu; Qian Chen; Xiaojuan Du; Litao Wu; Dan Cao; Chunyan Li; Shemin Lu; Dongmin Li
Journal:  Aging (Albany NY)       Date:  2022-04-11       Impact factor: 5.682

7.  iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine.

Authors:  Jiankun Yang; Lichao Yang; Baixue Li; Weilong Zhou; Sen Zhong; Zhenhua Zhuang; Bin Yang; Maoshan Chen; Quansheng Feng
Journal:  Biomed Res Int       Date:  2016-11-29       Impact factor: 3.411

8.  Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran.

Authors:  Yurong Xiong; Lihua Hu; Wei Zhou; Minghui Li; Tao Wang; Xiao Huang; Huihui Bao; Xiaoshu Cheng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Evaluation of bioenergetic and mitochondrial function in liver transplantation.

Authors:  Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Anabela Pinto Rolo; Carlos Marques Palmeira; José Guilherme Tralhão
Journal:  Clin Mol Hepatol       Date:  2019-03-22

10.  Early predictors of acute hepatitis B progression to liver failure.

Authors:  Qing-Fang Xiong; Tian Xiong; Ping Huang; Yan-Dan Zhong; Hua-Li Wang; Yong-Feng Yang
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.